27 Drydock Avenue
235 articles about Ginkgo Bioworks
Vivici has formed a partnership with Ginkgo to advance production of a sustainable and nutritious dairy protein, made via precision fermentation.
Concentric by Ginkgo Partners with Penn State University on Zoonotic Disease Biosurveillance Research Supported by USDA Grant
Ginkgo Bioworks announced it is joining efforts with Penn State University to integrate its biosurveillance capabilities into the university's research of 58 wildlife species for SARS-CoV-2 to monitor potential spillover to humans.
Persephone Biosciences and Ginkgo Bioworks Complete Reusable Bacteroides Anaerobic Engineering Toolkit
Persephone Biosciences Inc. and Ginkgo Bioworks announced the completion of their first collaboration together, a Bacteroides engineering toolkit.
Zenfold Leverages Ginkgo Enzyme Services to Enable Veterinary Active Ingredient Development with Sustainable Biology
Ginkgo Bioworks and Zenfold Sustainable Technologies announced a collaboration to leverage Ginkgo Enzyme Services in its effort to discover an enzyme critical to the manufacturing of veterinary products.
Concentric by Ginkgo to Support CDC-Funded Consortium to Develop New AI-Based Technologies for Epidemic Forecasting
Ginkgo Bioworks announced that its biosecurity and public health unit, Concentric by Ginkgo, will partner with Northeastern University, which has received a grant from the Centers of Disease Control and Prevention over the next five years to head an innovation center led by a consortium of organizations designed to help the United States to detect and prepare for the next outbreak of infectious disease.
Concentric By Ginkgo and Texas A&M University Awarded USDA NIFA AFRI Grant to Conduct Genomic Animal Research to Prevent Zoonotic Disease Spillover
Ginkgo Bioworks and Texas A&M University announced they have been jointly awarded a research grant from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service via the National Institute of Food and Agriculture, Agriculture and Food Research Initiative to study SARS-CoV-2 in white-tailed deer populations in Texas.
Ensovi Leverages Ginkgo Enzyme Services to Optimize Cell-Free Carbon Fixation Process for Biomanufacturing
Ensovi Inc. announced a new partnership with Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity.
Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug candidates.
Ginkgo Bioworks and the Government of the Republic of Madagascar Announce Plans to Develop New Biosecurity Capabilities
Ginkgo Bioworks and the Government of the Republic of Madagascar today announced that they have entered into a Memorandum of Understanding ("MOU") with the intent to develop and implement new biosecurity capabilities in Madagascar.
Factorial Biotechnologies and Ginkgo Bioworks Partner To Develop Enzyme for Single-Cell Library Prep Technology
Factorial Biotechnologies and Ginkgo Bioworks today announced a new collaboration.
Ceres Nanosciences and Ginkgo Bioworks Partner to Bring Pathogen Monitoring Capabilities to Labs Around the World
Ceres Nanosciences and Ginkgo Bioworks announced that they are partnering to bring pathogen monitoring capabilities to laboratories around the world.
Ginkgo Bioworks Holdings, Inc. announced that Anna Marie Wagner, Senior Vice President of Corporate Development, is scheduled to participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13 at 12:55 p.m. ET.
Exacta Bioscience and Ginkgo Bioworks Announce Partnership to Optimize Exacta's Crop Protection Product
Exacta Bioscience and Ginkgo Bioworks announced that Exacta is leveraging Ginkgo's end-to-end agricultural R&D services to run a fermentation optimization and scale-up program to enhance one of its crop protection products, FitoRoot®, paving the way for large-scale commercialization.
Ginkgo Bioworks Holdings, Inc., which is building the leading platform for cell programming and biosecurity, announced that it will hold an Investor Day on Tuesday, October 3, 2023, beginning at 10:00 am ET.
Concentric by Ginkgo and CGIAR International Livestock Research Institute (ILRI) announce collaboration on pathogen surveillance
Ginkgo Bioworks and the International Livestock Research Institute announced that they have entered into a Memorandum of Understanding with the intent to collaborate on pandemic surveillance work.
Ginkgo Bioworks Holdings, Inc. announced today that management is scheduled to participate in a panel discussion titled " Generative AI & Innovation Across Drug Discovery, Molecule Synthesis, & Precision Medicine " at the UBS MedTech, Tools and Genomics Summit 2023 on Tuesday, August 15 at 2:00 p.m. Pacific Time.
Ginkgo Bioworks Holdings, Inc., which is building the leading platform for cell programming and biosecurity, announced its results for the second quarter ended June 30, 2023.
Ginkgo Bioworks today announced a new collaboration with Merck, known as MSD outside of the United States and Canada, focused on improving biologic manufacturing.
Ginkgo Bioworks and the Government of the Republic of Panama Announce Plans to Establish New Biosecurity Capabilities
Ginkgo Bioworks, the leading horizontal platform for cell programming and biosecurity, and the Government of the Republic of Panama's Gorgas Memorial Institute for Health Studies, announced that they have entered into a Memorandum of Understanding with the intent to develop and implement new biosecurity capabilities in Latin America.
Ginkgo Bioworks today announced that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2023, on Wednesday, August 9, 2023, beginning at 5:30 p.m. ET.